Replies to post #67268 on MMRGlobal, Inc. (fka MMRF)

[tbone1360]

Morning Yeababy39, No Harm, No Foul, Friend

I am not the right 1 to ask exactly, I am beginning to get confused myself. Based on my Blue Button post yesterday, that seems to be old news. I'm not as sharp nor do I eat & breathe this like some others I know.

With that being said lets just ask a few of the guys with more intelligence than I. Tulza1, EZ, 3F, FJ74, BlackJack77, Recon4, Lickety Split etc.... Help the brother out. Come on SSC help him out, I know you aren't know fool.

Yeababy39, if MM (Marilyn Munroe) is right everyone here stands to make some money. Stay Safe!

All MMRF Boyardees, have a nice day!

B

[Frankinjohn74]

I am also wondering what happened to the Celgene deal.
We know by PRs/filings that the last milestone received was the one that was due NLT June 30, 2012. That was milestone "C" in the MMR/Celgene agreement. We are waiting on Milestone D:

Within ten (10) business days of FDA's acceptance

of CELGENE'S presentation and/or submission to FDA of the Surrogate Endpoint relying at least in part upon the Data Set... Acceptance shall mean CELGENE'S good faith understanding and belief of FDA's acceptance (as articulated at a meeting between CELGENE and FDA) of the Surrogate Endpoint as a regulatory endpoint in a Phase III clinical trial for the Product in the Field. In the event that said Acceptance does not occur MMRGLOBAL shall have the right to request a copy of the FDA-produced minutes from that meeting in order to confirm the non-Acceptance. In the event FDA does not ACCEPT the Surrogate Endpoint all remaining obligations under Article 4 shall immediately terminate. We also know that the Follicular Lymphoma Revlimid study most likely associated with this agreement will be done enrolling its 1000 patients this year. Understanding the accelerated FDA approval process it is highly improbable that Celgene and FDA did not already have this meeting. Relevant question: Did Celgene get endpoint acceptance from FDA using MMR's data set, or did it not. And if the latter, did MMR get the minutes as required from the Celgene/MMR agreement and where is the 8K saying the agreement is terminated if they did not accept?

http://www.secinfo.com/d12WKa.q5p.d.htm#1stPage